Literature DB >> 6796651

5-S-Cysteinyldopa in ganglion stellatum.

C Fehling, C Hansson, J Poulsen, H Rorsman, E Rosengren.   

Abstract

5-S-Cysteinyldopa, an amino acid formed by nucleophilic addition of cysteine to dopaquinone, has been detected in the ganglion stellatum of the cow in amounts varying between 21 and 35 ng/g ganglionic tissue. Dopa was present in slightly higher quantities. Cysteinyldopa has previously been regarded as a substance unique for the melanocytes, where it forms melanin after oxidation and polymerization. At present only hypothetical explanations of our finding can be offered. The content of 5-S-cysteinyldopa in ganglion stellatum may be the result of dopa oxidation in ganglionic cells. An uptake mechanism for circulating cysteinyldopa may exist. Localization of cysteinyldopa to aberrant melanocytes or to aged SIF-cells in the ganglia should also be borne in mind.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796651     DOI: 10.1007/BF01249607

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  11 in total

1.  THE DISTRIBUTION OF DOPAMINE AND DOPA IN VARIOUS ANIMALS AND A METHOD FOR THEIR DETERMINATION IN DIVERSE BIOLOGICAL MATERIAL.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1964-09       Impact factor: 4.030

2.  Fluorescence histochemical demonstration of dopa thioethers by condensation with gaseous formaldehyde.

Authors:  G Agrup; A Björklund; B Falck; S Jacobsson; O Lindvall; H Rorsman; E Rosengren
Journal:  Histochemistry       Date:  1977-05-20

3.  Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.

Authors:  H Thoenen; J P Tranzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

4.  A sensitive method for determination of 5-S-cysteinyldopa.

Authors:  H Rorsman; A M Rosengren; E Rosengren
Journal:  Acta Derm Venereol       Date:  1973       Impact factor: 4.437

5.  Cysteinyl dopa in human malignant melanoma.

Authors:  A Björklund; B Falck; S Jacobsson; H Rorsman; A M Rosengren; E Rosengren
Journal:  Acta Derm Venereol       Date:  1972       Impact factor: 4.437

6.  Model experiments on the molecular mechanism of action of 6-hydroxydopamine.

Authors:  A Saner; H Thoenen
Journal:  Mol Pharmacol       Date:  1971-03       Impact factor: 4.436

7.  Analysis of cysteinyldopas, dopa, dopamine, noradrenaline and adrenaline in serum and urine using high-performance liquid chromatography and electrochemical detection.

Authors:  C Hansson; G Agrup; H Rorsman; A M Rosengren; E Rosengren; L E Edholm
Journal:  J Chromatogr       Date:  1979-01-01

8.  5-hydroxydopa, a new compound in the Raper-Mason scheme of melanogenesis.

Authors:  C Hansson; H Rorsman; E Rosengren
Journal:  Acta Derm Venereol       Date:  1980       Impact factor: 4.437

9.  5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.

Authors:  G Agrup; C Hansson; H Rorsman; E Rosengren
Journal:  Acta Derm Venereol       Date:  1980       Impact factor: 4.437

10.  5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.

Authors:  G Agrup; T Andersson; B Falck; K Persson; H Rorsman; A M Rosengren; E Rosengren
Journal:  Acta Derm Venereol       Date:  1975       Impact factor: 4.437

View more
  2 in total

1.  Detection of 5-S-cysteinyldopamine in human brain.

Authors:  E Rosengren; E Linder-Eliasson; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

2.  Evidence of dopa in the nerves of sea anemones.

Authors:  M Carlberg
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.